Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-23

Clinical Trial Update: Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

This is a pilot Phase 1/2 clinical trial evaluating a curcumin formulation and an ashwagandha extract in advanced osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ashwagandha Extract (Withania somnifera extract)
  • Curcumin formulation (curcumin)

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Osteosarcoma | Phase 1, Phase 2 | Status: UNKNOWN